Oxford Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Oxford Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,771	Closed	-$416K	–	592
2025 Q2	$416K	Buy	41,771 +21,882	+110%	+$176K	0.14%	244
2025 Q1	$119K	Buy	+19,889	New	+$146K	0.05%	413

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oxford Asset Management's ITOS Position: Q3 2025 in Review

Oxford Asset Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 41,771 shares — an estimated $416K sold.

Oxford Asset Management first reported a position in ITOS in Q1 2025 and held it in 2 quarters. The position peaked at $416K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Oxford Asset Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 41,771 iTeos Therapeutics shares in Q3 2025, an estimated $416K.
Oxford Asset Management first reported a position in iTeos Therapeutics in Q1 2025 and held it in 2 quarters.
Oxford Asset Management's iTeos Therapeutics position peaked at $416K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.